We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 16

Patient matters supply of medicines - NHS permitted under EU law to incentivise money-saving prescribing practices
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • June 14 2010

The European Court of Justice (ECJ) ruled in April in Association of the British pharmaceutical industry (ABPI) v Medicines and Healthcare Products Regulatory Agency (MHRA) case C-6209) that an incentive scheme operated by certain NHS bodies in England and Wales in a bid to reduce costs relating to prescription medicines did not breach European Union (EU) law


An update on PIP implants
  • Mills & Reeve LLP
  • European Union, France, United Kingdom
  • April 24 2014

In 1997, French company Poly Implant Prothèse (PIP) gained CE mark approval to produce breast implants using medical grade silicone. CE marking is


Clinical trials - greater transparency and uniformity across Europe
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • August 11 2014

The trend in clinical research is increasingly global. This means that, as well as multi-country trials becoming more common, there is competition


European Court of Human Rights (ECHR) supports the ruling in Rabone
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • July 11 2012

In the case of Reynolds v The UK, Mrs Reynolds appealed a decision of the county court that she was not entitled to damages following the death of her son


Cosmetic interventions and regulation
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • January 20 2014

While group litigation concerning the issues around PIP implants continues, there were developments last month in the ongoing discussions around the


New procurement directives come into force
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • April 17 2014

New EU procurement directives come into force today, 17 April 2014. The UK government now has two years to implement the new rules into national law


Challenge to seclusion policy on the basis of human rights
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • September 17 2012

Following an unsuccessful application to the House of Lords, Colonel Munjaz (a patient detained under the Mental Health Act 1983) challenged the legality of Ashworth Hospital’s seclusion policy on the grounds that it violated his human rights as set out in the European Convention on Human Rights


End to competence tests for EU nurses
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • September 7 2010

The constraints placed on the UK by EU law in relation to the employment of EU nationals, can be demonstrated by the recent decision of the Nursing and Midwifery Council (NMC) to agree to the end of competency tests for workers from the European Union (EU) after being told it could be sued by the European Commission for breaching EU law on "the freedom of movement" for workers


Department of Health to take action on language testing for European Economic Area doctors
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • September 7 2010

The Government has published its Response to the House of Commons Health Committee report into the use of overseas doctors in providing out of hours services, (the response) which was commissioned following the death of David Gray, a patient of Dr Ubani from Germany who was working as an out of hours doctor, despite having previously failed a language test to work in this country


Pharmacists will be able to supply medicines prescribed by EU doctors
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • August 13 2008

By virtue of the Medicines for Human Use (Prescribing by EEA practitioners) Regulations 2008, which come into force on 3 November 2008, pharmacists will be able to sell or supply medicines prescribed by doctors or dentists in EEA states (other than the UK) and Switzerland, subject to certain exceptions